


<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
         xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
    <responseDate>2025-09-09T13:47:34Z</responseDate>
    <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:12405615" metadataPrefix="pmc">https://pmc.ncbi.nlm.nih.gov/api/oai/v1/mh/</request>
    
    <GetRecord>
        <record>
    <header>
    <identifier>oai:pubmedcentral.nih.gov:12405615</identifier>
    <datestamp>2025-09-04</datestamp>
    
        
        <setSpec>scirep</setSpec>
        
    
        
        <setSpec>pmc-open</setSpec>
        
    
</header>
    <metadata>
        
        <article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.4/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.4/ https://jats.nlm.nih.gov/archiving/1.4/xsd/JATS-archivearticle1-4.xsd" article-type="research-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Sci Rep</journal-id><journal-id journal-id-type="iso-abbrev">Sci Rep</journal-id><journal-id journal-id-type="pmc-domain-id">1579</journal-id><journal-id journal-id-type="pmc-domain">scirep</journal-id><journal-title-group><journal-title>Scientific Reports</journal-title></journal-title-group><issn pub-type="epub">2045-2322</issn><publisher><publisher-name>Nature Publishing Group</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12405615</article-id><article-id pub-id-type="pmcid-ver">PMC12405615.1</article-id><article-id pub-id-type="pmcaid">12405615</article-id><article-id pub-id-type="pmcaiid">12405615</article-id><article-id pub-id-type="pmid">40897764</article-id><article-id pub-id-type="doi">10.1038/s41598-025-14685-7</article-id><article-id pub-id-type="publisher-id">14685</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Epidemiology and co-infection patterns of community-acquired pneumonia among children from 2015 to 2023 in Henan Province, China: longitudinal surveillance study</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Li</surname><given-names initials="T">Tianyu</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Chen</surname><given-names initials="S">Shouhang</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Shen</surname><given-names initials="Y">Yuanfang</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Li</surname><given-names initials="Z">Zhi</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Han</surname><given-names initials="S">Shujuan</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Yuan</surname><given-names initials="Y">Yan</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zhang</surname><given-names initials="Y">Yaodong</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Feng</surname><given-names initials="D">Demin</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Jin</surname><given-names initials="Z">Zhipeng</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Jin</surname><given-names initials="Y">Yuefei</given-names></name><address><email>jyf201907@zzu.edu.cn</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Wang</surname><given-names initials="F">Fang</given-names></name><address><email>13783637576@139.com</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01jfd9z49</institution-id><institution-id institution-id-type="GRID">grid.490612.8</institution-id><institution>Department of Infectious Diseases, Henan Children&#8217;s Hospital, </institution><institution>Children&#8217;s Hospital Affiliated to Zhengzhou University, Zhengzhou Children&#8217;s Hospital, </institution></institution-wrap>Zhengzhou, 450018 Henan Province China </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/04ypx8c21</institution-id><institution-id institution-id-type="GRID">grid.207374.5</institution-id><institution-id institution-id-type="ISNI">0000 0001 2189 3846</institution-id><institution>College of Public Health, </institution><institution>Zhengzhou University, </institution></institution-wrap>Zhengzhou, 450001 Henan Province China </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01jfd9z49</institution-id><institution-id institution-id-type="GRID">grid.490612.8</institution-id><institution>Henan International Joint Laboratory of Children&#8217;s Infectious Diseases, Henan Children&#8217;s Hospital, </institution><institution>Children&#8217;s Hospital Affiliated to Zhengzhou University, Zhengzhou Children&#8217;s Hospital, </institution></institution-wrap>Zhengzhou, 450018 China </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/039nw9e11</institution-id><institution-id institution-id-type="GRID">grid.412719.8</institution-id><institution>The Third Affiliated Hospital of Zhengzhou University, </institution></institution-wrap>Zhengzhou, 450052 China </aff><aff id="Aff5"><label>5</label>Pingyuan Laboratory, Xinxiang, 453007 China </aff></contrib-group><pub-date pub-type="epub"><day>2</day><month>9</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>15</volume><issue-id pub-id-type="pmc-issue-id">478255</issue-id><elocation-id>32347</elocation-id><history><date date-type="received"><day>27</day><month>5</month><year>2025</year></date><date date-type="accepted"><day>1</day><month>8</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>02</day><month>09</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>04</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-04 00:25:59.930"><day>04</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article&#8217;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#8217;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link>.</license-p></license></permissions><self-uri content-type="pmc-pdf" xlink:href="41598_2025_Article_14685.pdf"/><abstract id="Abs1"><p id="Par8">Community-acquired pneumonia (CAP) remains one of the most prevalent infectious diseases affecting children worldwide. Despite its global significance, we still lack comprehensive epidemiological data and pathogen profiles specifically for Pediatric CAP cases in Henan Province, China. We analyzed clinical data from children with CAP admitted to Children&#8217;s Hospital Affiliated to Zhengzhou University and Zhengzhou University&#8217;s Third Affiliated Hospital between 2015 and 2023. Using time-series analysis, we projected CAP prevalence trends for 2024.&#160;There existed notable seasonal and regional disparities in the incidence of pediatric CAP cases in Henan Province. The incidence peak of pediatric CAP cases occurred from May to August. Moreover, school-aged and preschool children were at a higher risk of contracting CAP. Among pediatric CAP cases, the disease spectrum varied according to age. Mycoplasma pneumonia (MP) was the main pathogen, presenting in diverse infection patterns and multiple mixed infection combinations. The time series prediction model based on ARIMA suggested that the incidence of pediatric CAP would decrease in 2024. Collectively, the incidence of CAP in children in Henan Province shows a seasonal upward trend. The primary cause of infection is identified as MP, and it is often combined with various bacteria and viruses in different age groups.</p><sec><title>Supplementary Information</title><p>The online version contains supplementary material available at 10.1038/s41598-025-14685-7.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Community-acquired pneumonia</kwd><kwd>Mycoplasma pneumonia</kwd><kwd>Children</kwd><kwd>Epidemiology</kwd></kwd-group><kwd-group kwd-group-type="npg-subject"><title>Subject terms</title><kwd>Diseases</kwd><kwd>Health care</kwd><kwd>Molecular medicine</kwd></kwd-group><funding-group><award-group><funding-source><institution>Open Grant from the Pingyuan Laboratory</institution></funding-source><award-id>No. 2023PY-OP-0202</award-id><award-id>No. 2023PY-OP-0202</award-id><award-id>No. 2023PY-OP-0202</award-id><principal-award-recipient><name name-style="western"><surname>Li</surname><given-names>Tianyu</given-names></name><name name-style="western"><surname>Li</surname><given-names>Zhi</given-names></name><name name-style="western"><surname>Jin</surname><given-names>Yuefei</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution>Open Project of Henan Province Engineering Research Center of Diagnosis and Treatment of Pediatric Infection and Critical Care</institution></funding-source><award-id>No. ERC202302</award-id><award-id>No. ERC202302</award-id><award-id>No. ERC202302</award-id><award-id>No. ERC202302</award-id><award-id>No. ERC202302</award-id><award-id>No. ERC202302</award-id><award-id>No. ERC202302</award-id><award-id>No. ERC202302</award-id><award-id>No. ERC202302</award-id><principal-award-recipient><name name-style="western"><surname>Li</surname><given-names>Tianyu</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Shouhang</given-names></name><name name-style="western"><surname>Shen</surname><given-names>Yuanfang</given-names></name><name name-style="western"><surname>Han</surname><given-names>Shujuan</given-names></name><name name-style="western"><surname>Yuan</surname><given-names>Yan</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Yaodong</given-names></name><name name-style="western"><surname>Jin</surname><given-names>Zhipeng</given-names></name><name name-style="western"><surname>Jin</surname><given-names>Yuefei</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Fang</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100002858</institution-id><institution>China Postdoctoral Science Foundation</institution></institution-wrap></funding-source><award-id>No. 2024T170246</award-id><principal-award-recipient><name name-style="western"><surname>Jin</surname><given-names>Yuefei</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution>Zhengzhou Science and Technology Beneficiary Program Project</institution></funding-source><award-id>No. 2022KJHM0004</award-id><principal-award-recipient><name name-style="western"><surname>Jin</surname><given-names>Yuefei</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution>Open Project of Key Laboratory of Infection and Immunity of Anhui Higher Education Institutes</institution></funding-source><award-id>No. I&amp;I-2024-R01</award-id><principal-award-recipient><name name-style="western"><surname>Jin</surname><given-names>Yuefei</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution>Open Project of Key Laboratory of Children&#8217;s Disease Research in Guangxi&#8217;s Colleges and Universities</institution></funding-source><award-id>No. GXCDR202401</award-id><principal-award-recipient><name name-style="western"><surname>Jin</surname><given-names>Yuefei</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution>Program for Innovative Talents in Higher Education Institutions of Henan Province</institution></funding-source><award-id>No. 25HASTIT055</award-id><principal-award-recipient><name name-style="western"><surname>Jin</surname><given-names>Yuefei</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution>Outstanding Youth Science Foundation of Henan Province</institution></funding-source><award-id>No. 252300421122</award-id><principal-award-recipient><name name-style="western"><surname>Jin</surname><given-names>Yuefei</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution>Jointly-built Project of Henan Province Medical Science and Technology Research Program</institution></funding-source><award-id>LHGJ20210470</award-id><principal-award-recipient><name name-style="western"><surname>Jin</surname><given-names>Yuefei</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; Springer Nature Limited 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par9">Pneumonia, as a common severe respiratory infection among children, accounts for a significant proportion of childhood morbidity and mortality<sup><xref ref-type="bibr" rid="CR1">1</xref></sup> and has an estimated cost of nearly $1&#160;billion in the United States<sup><xref ref-type="bibr" rid="CR2">2</xref></sup>. Furthermore, pneumonia remains the leading cause of death among young children in low-income countries and elderly individuals in high-income countries<sup><xref ref-type="bibr" rid="CR3">3</xref>,<xref ref-type="bibr" rid="CR4">4</xref></sup>. Despite the significant disease burden, there are still critical gaps in our understanding of pediatric pneumonia<sup><xref ref-type="bibr" rid="CR5">5</xref></sup>. Community-acquired pneumonia (CAP) is one of the most common serious respiratory infections in hospitalized children<sup><xref ref-type="bibr" rid="CR6">6</xref></sup>. Over the past three decades, conjugate vaccines have effectively reduced the prevalence of Streptococcus pneumonia and Haemophilus influenzae type b, which were previously the primary causes of CAP<sup><xref ref-type="bibr" rid="CR7">7</xref></sup>. Currently, Mycoplasma pneumonia (MP) and viruses are the most frequently identified pathogens in children with CAP<sup><xref ref-type="bibr" rid="CR8">8</xref>,<xref ref-type="bibr" rid="CR9">9</xref></sup>. Thus far, as the most densely populated province in China, Henan Province still exhibits a relative dearth of knowledge regarding CAP among children. In the present study, we conducted a longitudinal surveillance study and describe the specific epidemiological and clinical features of CAP among hospitalized children from 2015 to 2023 in Henan Province located in Central China. This will provide a prospective decision-making basis for public health departments and help optimize and implement disease prevention and control strategies, serving as a valuable tool for academic research and policy development in the field of public health.</p></sec><sec id="Sec2"><title>Methods</title><sec id="Sec3"><title>Study design and case definition</title><p id="Par10">This retrospective study analyzed the clinical data of children under 18 years of age with community-acquired pneumonia who were hospitalized at Henan Children&#8217;s Hospital (National Children&#8217;s Regional Medical Center) and the Third Affiliated Hospital of Zhengzhou University during 2015&#8211;2023. Children were included if they (1) were hospitalized with clinically suspected CAP, with pneumonia diagnosis confirmed by chest radiography as the reference standard; (2) were diagnosed within 24&#160;h of the admission; 3) were from Henan Province. All radiographic findings suggestive of pneumonia required the independent interpretation of chest radiographs by a certified radiologist.</p><p id="Par11">Children were excluded if they (1) had immunodeficiency; (2) lived beyond the borders of Henan Province; (3) Clinically suggestive of URI (Upper respiratory infections)/bronchitis (e.g. predominant rhinorrhea/wheezing) AND Lack of consolidative changes on chest imaging; (4) were transferred from other medical facilities or were not initially diagnosed at the designated sentinel hospitals.</p><p id="Par12">CAP diagnosis followed Pediatric Infectious Diseases Society (PIDS)/Infectious Diseases Society of America (IDSA) (2011) guidelines<sup><xref ref-type="bibr" rid="CR10">10</xref></sup> requiring both:<list list-type="order"><list-item><p id="Par13">Clinical criteria: Presence of &#8805;&#8201;1 cardinal respiratory symptom (fever&#8201;&#8805;&#8201;38&#160;&#176;C, cough, age-specific tachypnea, dyspnea, or chest pain) combined with &#8805;&#8201;1 of the following:<list list-type="order"><list-item><p id="Par14">Physical signs: Nasal flaring, grunting, or auscultatory abnormalities (crackles/bronchial breath sounds);</p></list-item><list-item><p id="Par15">Chest percussion dullness.</p></list-item></list></p></list-item></list><list list-type="simple"><list-item><label>2.</label><p id="Par16">Ancillary criteria (hospitalized cases):<list list-type="order"><list-item><p id="Par17">Hypoxemia (SpO&#8322; &lt;90% at sea level);</p></list-item><list-item><p id="Par18">Radiologic confirmation via posteroanterior and lateral chest X-ray (CXR) demonstrating pulmonary infiltrates.</p></list-item></list></p></list-item></list></p><p id="Par19">While CXR remained the diagnostic gold standard, imaging was intentionally restricted to hospitalized patients and severe outpatient cases in alignment with guideline recommendations to minimize radiation exposure in mild, uncomplicated CAP.</p><p id="Par20">According to Pocket Book of Hospital Care for Children<sup><xref ref-type="bibr" rid="CR11">11</xref></sup> the diagnostic criteria for severe community-acquired pneumonia (SCAP) in patients under 18 years of age are defined as the presence of cough or dyspnea along with at least one of the following clinical manifestations:<list list-type="order"><list-item><p id="Par21">Central cyanosis or oxygen saturation (SpO&#8322;)&#8201;&lt;&#8201;90% on pulse oximetry;</p></list-item><list-item><p id="Par22">Severe respiratory distress;</p></list-item><list-item><p id="Par23">Presence of any general danger signs, including:<list list-type="simple"><list-item><label>&#9312;</label><p id="Par24">Inability to breastfeed or drink;</p></list-item><list-item><label>&#9313;</label><p id="Par25">Altered mental status (lethargy or unconsciousness);</p></list-item><list-item><label>&#9314;</label><p id="Par26">Convulsions.</p></list-item></list></p></list-item></list></p><p id="Par27">To enable a more precise examination of the attributes displayed by children across different age group, we have categorized the entire cohort into four distinct age groups. These age groups are defined as: &lt;1 year (infants), 1&#8211;2 years old, 3&#8211;5 years old, and 6&#8211;18 years old.</p></sec><sec id="Sec4"><title>Data collection</title><p id="Par28">The study utilized inpatient and outpatient medical records, which included demographic information, clinical timelines, diagnostic test results, and patient outcomes. Trained clinicians systematically entered these comprehensive data into a centralized database to ensure accuracy and completeness.</p><p id="Par29">This study utilized a stratified random sampling method integrated with detection-adjusted weighting to select 2,000 cases from 24,359 pediatric hospitalized cases of CAP between 2015 and 2023 for pathogen analysis. The detailed process was presented in Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref> of Supplementary Material 1. The sample size was determined based on the following considerations: (1) statistical requirements to detect&#8201;&#8805;&#8201;12% absolute differences in the prevalence of Mycoplasma pneumonia (&#945;&#8201;=&#8201;0.05, power&#8201;=&#8201;80%), and (2) practical constraints requiring adjustment for substantial annual variations in negative detection rates (14&#8211;45%).</p><p id="Par30">Sampling prioritized bronchoalveolar lavage (BAL) specimens, severe cases, and pre-antibiotic samples, with 15% of negative results validated by metagenomic next-generation sequencing (mNGS). This dual-correction design effectively minimized sampling bias caused by variations in detection efficiency and pathogen epidemic cycles.</p></sec><sec id="Sec5"><title>Ethical considerations</title><p id="Par31">The study protocol was approved by the Life Sciences Institutional Review Board of Zhengzhou University (ZZUIRB2023-180). To ensure privacy and confidentiality, the individual CAP data were anonymized by deleting the personal identifiers.</p></sec><sec id="Sec6"><title>Laboratory testing</title><p id="Par32">Laboratory testing strictly adhered to standardized clinical protocols, ensuring consistent sample collection and analysis methods for all community-acquired pneumonia patients. Gram staining and bacterial culture were performed on blood, pleural fluid, endotracheal aspirates, and bronchoalveolar lavage specimens using established methodologies. Only high-quality endotracheal aspirates and quantified bronchoalveolar lavage samples meeting predefined criteria were included in the analysis.</p><p id="Par33">Real-time polymerase chain reaction (PCR) testing conducted at Children&#8217;s Hospital Affiliated to Zhengzhou University and Zhengzhou University&#8217;s Third Affiliated Hospital targeted the following pathogens:</p><p id="Par34">Streptococcus pneumonia (lyt-A gene) and Streptococcus pyogenes (spy gene) in blood and pleural fluid samples.</p><p id="Par35">Additionally, pleural fluid was screened for Haemophilus influenzae, Staphylococcus aureus, Streptococcus anginosus/mitis, and other Gram-negative bacteria.</p><p id="Par36">Nasopharyngeal and oropharyngeal swabs were analyzed for respiratory pathogens, including:</p><p id="Par37">Viruses: adenovirus, influenza A/B, parainfluenza viruses 1&#8211;3, respiratory syncytial virus, human rhinovirus, bocavirus, cytomegalovirus, and herpes simplex virus.</p><p id="Par38">Bacteria: Klebsiella pneumonia, and Haemophilus parainfluenzae.</p><p id="Par39">Atypical bacteria: Mycoplasma pneumonia and Chlamydophila pneumonia.</p><p id="Par40">Serological testing for adenovirus, human metapneumovirus, influenza A/B, parainfluenza viruses, and respiratory syncytial virus was performed using paired acute and convalescent serum samples. Comprehensive quality control measures ensured standardization and consistency across all study sites.</p><p id="Par41">The IDSA guidelines provide evidence-based recommendations for distinguishing bacterial, viral, and Mycoplasma pneumonia in children. Below are the key diagnostic criteria for each type:<list list-type="order"><list-item><p id="Par42">Bacterial pneumonia<list list-type="bullet"><list-item><label/><p id="Par44">Clinical features:<list list-type="bullet"><list-item><label/><p id="Par45">Acute onset with high-grade fever (&gt;&#8201;39&#160;&#176;C);</p></list-item><list-item><label/><p id="Par46">Tachypnea, chest pain, focal crackles, or signs of consolidation (e.g., dullness to percussion);</p></list-item><list-item><label/><p id="Par47">Systemic toxicity (lethargy, poor perfusion).</p></list-item></list></p></list-item><list-item><label/><p id="Par48">Laboratory findings:<list list-type="bullet"><list-item><label/><p id="Par49">Leukocytosis (&gt;&#8201;15,000/&#181;L) with neutrophilic predominance;</p></list-item><list-item><label/><p id="Par50">Markedly elevated inflammatory markers (C-reactive protein [CRP]&#8201;&gt;&#8201;40&#8211;60&#160;mg/L; procalcitonin&#8201;&gt;&#8201;0.5 ng/mL).</p></list-item></list></p></list-item><list-item><label/><p id="Par51">Radiological features (Chest X-ray):<list list-type="bullet"><list-item><label/><p id="Par52">Lobar/segmental consolidation;</p></list-item><list-item><label/><p id="Par53">Pleural effusion (highly specific for bacterial etiology).</p></list-item></list></p></list-item><list-item><label/><p id="Par54">Microbiological confirmation:<list list-type="bullet"><list-item><label/><p id="Par55">Positive blood culture (detection rate: 1.4&#8211;11.4% in hospitalized children);</p></list-item><list-item><label/><p id="Par56">Pathogen identification from pleural fluid culture/polymerase chain reaction (PCR; e.g., Streptococcus pneumonia, Staphylococcus aureus).</p></list-item></list></p></list-item></list></p></list-item><list-item><p>Viral pneumonia<list list-type="bullet"><list-item><label/><p>Clinical features:<list list-type="bullet"><list-item><label/><p id="Par60">Predominance in children&#8201;&lt;&#8201;5 years;</p></list-item><list-item><label/><p id="Par61">Preceding upper respiratory infection symptoms (rhinorrhea, cough);</p></list-item><list-item><label/><p id="Par62">Wheezing with low-grade fever (&lt;&#8201;38.5&#160;&#176;C).</p></list-item></list></p></list-item><list-item><label/><p id="Par63">Laboratory findings:<list list-type="bullet"><list-item><label/><p id="Par64">Normal/mildly elevated white blood cell count (lymphocytic predominance);</p></list-item><list-item><label/><p id="Par65">CRP and procalcitonin typically within normal range.</p></list-item></list></p></list-item><list-item><label/><p id="Par66">Radiological features (Chest X-ray):<list list-type="bullet"><list-item><label/><p id="Par67">Bilateral interstitial infiltrates;</p></list-item><list-item><label/><p id="Par68">Patchy perihilar opacities.</p></list-item></list></p></list-item><list-item><label/><p id="Par69">Microbiological confirmation:<list list-type="bullet"><list-item><label/><p id="Par70">Positive nasopharyngeal swab PCR/antigen testing (e.g., influenza, respiratory syncytial virus, adenovirus).</p></list-item></list></p></list-item></list></p></list-item><list-item><p>Mycoplasma <italic toggle="yes">pneumonia</italic> Pneumonia<list list-type="bullet"><list-item><label/><p id="Par73">Clinical features:<list list-type="bullet"><list-item><label/><p id="Par74">Predominance in school-aged children/adolescents;</p></list-item><list-item><label/><p id="Par75">Insidious onset with persistent dry cough (&gt;&#8201;1 week);</p></list-item><list-item><label/><p id="Par76">Clinical-radiographic dissociation: paucity of auscultatory findings despite significant radiographic abnormalities.</p></list-item></list></p></list-item><list-item><label/><p id="Par77">Laboratory findings:<list list-type="bullet"><list-item><label/><p id="Par78">Positive <italic toggle="yes">M. pneumonia</italic>-specific IgM serology (ELISA/rapid immunoassay);</p></list-item><list-item><label/><p id="Par79">PCR detection in respiratory specimens (e.g., sputum, throat swab).</p></list-item></list></p></list-item><list-item><label/><p id="Par80">Radiological features (Chest X-ray):<list list-type="bullet"><list-item><label/><p id="Par81">Unilateral patchy consolidation or peribronchial infiltrates;</p></list-item><list-item><label/><p id="Par82">Lobar consolidation uncommon (&lt;&#8201;15% of cases).</p></list-item></list></p></list-item></list></p></list-item></list></p></sec><sec id="Sec7"><title>Statistical analysis</title><p id="Par83">Categorical variables were summarized as proportions, while continuous variables were presented as medians with interquartile ranges (IQR). We quantified the burden of CAP within the hospitalized population using the hospital CAP hospitalization rate, calculated as: Hospital CAP hospitalization rate = [Number of CAP hospitalizations during the study period]/[Total number of hospitalizations during the same period] &#215; Benchmark value (e.g., 1000&#8240; or 100%). Inter-group differences were evaluated using &#967;&#178; tests or Fisher&#8217;s exact tests, as appropriate.</p><p id="Par84">Morlet wavelet analysis implemented in MATLAB identified temporal periodicity patterns, which were visualized through wavelet coefficients.</p><p id="Par85">Following data preprocessing in Excel, the expert modeler in SPSS automatically determined the optimal autoregressive integrated moving average (ARIMA) parameters for modeling temporal trends<sup><xref ref-type="bibr" rid="CR12">12</xref></sup>.</p></sec></sec><sec id="Sec8"><title>Results</title><sec id="Sec9"><title>Basic characteristics of children with CAP in Henan Province from 2015 to 2023</title><p id="Par86">A total of 24,359 patients hospitalized for CAP between January 1, 2015 and December 31, 2023 were included in this study (Table&#160;<xref rid="Tab1" ref-type="table">1</xref>). The cohort consisted of 13,149 males (male: female ratio&#8201;=&#8201;1.2:1), with ages spanning from neonates (<italic toggle="yes">n</italic>&#8201;=&#8201;28) to 17 years. Age-stratified analysis indicated the highest proportion distribution of hospitalization in children aged 6&#8211;18 years (11,467 cases, 47.08%) and 3&#8211;5 years (8,665 cases, 35.57%; <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.01 compared to younger age groups). CAP accounted for 1.76% of total hospitalizations during the study period, showing a significant male predominance across all age groups (all <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05). Notably, children aged 3&#8211;8 years constituted the highest-risk subgroup, representing 51.74% of all CAP cases (12,603 cases). The gender-specific analysis results indicated that the standardized incidence rates for boys and girls aged 3 to 8 years were comparable (67.07% vs. 69.90%, <italic toggle="yes">p</italic>&#8201;&gt;&#8201;0.05). However, the cumulative number of cases among boys was significantly higher than that among girls (7,812 vs. 4,791) (Supplementary Material 1, Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref>).</p><p id="Par87">Urban residents constituted a significantly higher proportion of CAP cases compared to rural residents (69.3% vs. 30.7%, <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001). Notably, the number of urban CAP cases showed a progressive increase starting from 2018, resulting in a six-fold predominance of urban cases over rural cases by 2023 (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001). A temporary decline in case numbers was observed in both urban and rural settings during 2020 (Table&#160;<xref rid="Tab1" ref-type="table">1</xref>).</p><p id="Par88">
<table-wrap id="Tab1" position="float" orientation="portrait"><label>Table 1</label><caption><p>Basic characteristics of children with CAP in Henan Province from 2015 to 2023.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Variable</th><th align="left" colspan="1" rowspan="1">Total (<italic toggle="yes">n</italic>&#8201;=&#8201;24359)</th><th align="left" colspan="1" rowspan="1">Male (<italic toggle="yes">n</italic>&#8201;=&#8201;13149)</th><th align="left" colspan="1" rowspan="1">Female (<italic toggle="yes">n</italic>&#8201;=&#8201;11210)</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Age (in years) at diagnosis, median (IQR)</td><td align="left" colspan="1" rowspan="1">5.5 (3.5&#8211;7.5)</td><td align="left" colspan="1" rowspan="1">5.5 (3.5&#8211;7.5)</td><td align="left" colspan="1" rowspan="1">5.5 (3.5&#8211;7.5)</td></tr><tr><td align="left" colspan="4" rowspan="1">Number of cases hospitalized with CAP by age group at diagnosis</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Total (0&#8211;18)</td><td align="left" colspan="1" rowspan="1">24,359 (1.76%)</td><td align="left" colspan="1" rowspan="1">13,149 (0.95%)</td><td align="left" colspan="1" rowspan="1">11,210 (0.81%)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&lt;1</td><td align="left" colspan="1" rowspan="1">904</td><td align="left" colspan="1" rowspan="1">556</td><td align="left" colspan="1" rowspan="1">348</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;1&#8211;2</td><td align="left" colspan="1" rowspan="1">3297</td><td align="left" colspan="1" rowspan="1">1871</td><td align="left" colspan="1" rowspan="1">1426</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;3&#8211;5</td><td align="left" colspan="1" rowspan="1">8701</td><td align="left" colspan="1" rowspan="1">4640</td><td align="left" colspan="1" rowspan="1">4061</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;6&#8211;18</td><td align="left" colspan="1" rowspan="1">11,457</td><td align="left" colspan="1" rowspan="1">6082</td><td align="left" colspan="1" rowspan="1">5375</td></tr><tr><td align="left" colspan="4" rowspan="1">Number of cases hospitalized with CAP by geographical region</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Urban</td><td align="left" colspan="1" rowspan="1">16,881</td><td align="left" colspan="1" rowspan="1">8913</td><td align="left" colspan="1" rowspan="1">7968</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Rural</td><td align="left" colspan="1" rowspan="1">7478</td><td align="left" colspan="1" rowspan="1">4236</td><td align="left" colspan="1" rowspan="1">3242</td></tr><tr><td align="left" colspan="4" rowspan="1">Number of cases hospitalized with CAP by diagnosis year</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;2015</td><td align="left" colspan="1" rowspan="1">1420</td><td align="left" colspan="1" rowspan="1">817</td><td align="left" colspan="1" rowspan="1">603</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;2016</td><td align="left" colspan="1" rowspan="1">1270</td><td align="left" colspan="1" rowspan="1">746</td><td align="left" colspan="1" rowspan="1">524</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;2017</td><td align="left" colspan="1" rowspan="1">2022</td><td align="left" colspan="1" rowspan="1">1127</td><td align="left" colspan="1" rowspan="1">895</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;2018</td><td align="left" colspan="1" rowspan="1">1437</td><td align="left" colspan="1" rowspan="1">759</td><td align="left" colspan="1" rowspan="1">678</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;2019</td><td align="left" colspan="1" rowspan="1">3037</td><td align="left" colspan="1" rowspan="1">1649</td><td align="left" colspan="1" rowspan="1">1388</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;2020</td><td align="left" colspan="1" rowspan="1">1186</td><td align="left" colspan="1" rowspan="1">617</td><td align="left" colspan="1" rowspan="1">569</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;2021</td><td align="left" colspan="1" rowspan="1">2404</td><td align="left" colspan="1" rowspan="1">1320</td><td align="left" colspan="1" rowspan="1">1084</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;2022</td><td align="left" colspan="1" rowspan="1">2139</td><td align="left" colspan="1" rowspan="1">1135</td><td align="left" colspan="1" rowspan="1">1004</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;2023</td><td align="left" colspan="1" rowspan="1">9444</td><td align="left" colspan="1" rowspan="1">4979</td><td align="left" colspan="1" rowspan="1">4465</td></tr></tbody></table><table-wrap-foot><p><italic toggle="yes">IQR</italic> interquartile rang.</p></table-wrap-foot></table-wrap>
</p></sec><sec id="Sec10"><title>Regional distribution of children with CAP in Henan Province from 2015 to 2023</title><p id="Par89">Geospatial analysis revealed significant heterogeneity in the distribution of CAP cases across Henan Province (Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>). Zhengzhou accounted for the majority of cases (15,718; 64.53%), followed by Zhoukou and Zhumadian. In contrast, the lowest prevalence was observed in Puyang (65 cases; 0.27%), Hebi (72 cases; 0.30%), and Sanmenxia (34 cases; 0.14%).</p><p id="Par90">Notably, during 2020&#8211;2022, CAP incidence remained suppressed throughout most of Henan Province, with the exception of Zhengzhou. However, temporal trends from 2019 to 2023 demonstrated consistent epidemiological patterns across all cities (<italic toggle="yes">p</italic>&#8201;=&#8201;0.15 for regional variation), indicating synchronized transmission dynamics despite differences in baseline incidence rates.</p><p id="Par91">
<fig id="Fig1" position="float" orientation="portrait"><label>Fig. 1</label><caption><p>Regional distribution of hospitalized children with CAP in Henan Province, 2015&#8211;2023. A total of 24,359 patients hospitalized for CAP between January 1, 2015 and December 31, 2023 were included in this study. We categorized the cases based on various regions and illustrated the characteristics of regional distribution over time.</p></caption><graphic id="d33e883" position="float" orientation="portrait" xlink:href="41598_2025_14685_Fig1_HTML.jpg"/></fig>
</p></sec><sec id="Sec11"><title>Time trend and seasonal pattern of CAP in children in Henan Province</title><p id="Par92">CAP incidence exhibited distinct seasonal patterns, with consistent winter-spring peaks observed annually (Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref>A). A notable epidemiological shift occurred in 2020, when case numbers began rising from September-October and peaked during February-March. After 2021, this pattern evolved to include secondary surges starting each April-May, followed by declines in July-August, and resurgence from September through March of the following year.</p><p id="Par93">Annual trends demonstrated progressive increases in CAP-related hospitalizations, reaching a peak in 2019. Following a temporary decline in 2020, case numbers rebounded significantly during 2021&#8211;2023, surpassing all prior records. Notably, an unprecedented surge began in 2023, with both absolute case numbers and hospitalization proportions exceeding historical levels (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.01).</p><p id="Par94">Male patients exhibited significantly higher CAP morbidity and hospitalization rates compared to females (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001; Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref>B), underscoring gender-based susceptibility differences. Age-stratified analysis further revealed substantial disparities, with elderly patients demonstrating markedly higher incidence and hospitalization rates compared to younger populations (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.01).</p><p id="Par95">From 2015 to 2023, the distribution of hospitalizations by age group followed this pattern: 6&#8211;18 years&#8201;&gt;&#8201;3&#8211;5 years&#8201;&gt;&#8201;1&#8211;2 years&#8201;&gt;&#8201;&lt;&#8201;1 year. While the &lt;&#8201;1 year and 1&#8211;2 years groups showed minor proportional fluctuations, the 3&#8211;5 years and 6&#8211;18 years groups aligned closely with the overall epidemiological trends. Notably, the 6&#8211;18 years cohort exhibited the most pronounced temporal variations (Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref>C).</p><p id="Par96">
<fig id="Fig2" position="float" orientation="portrait"><label>Fig. 2</label><caption><p>Monthly distribution of cases (bars) and component ratio of (lines) CAP from 24,359 hospitalized children in Henan Province from 2015 to 2023. (<bold>A</bold>) Overall cases, (<bold>B</bold>) Classification by gender, (<bold>C</bold>) Classification by age.</p></caption><graphic id="d33e931" position="float" orientation="portrait" xlink:href="41598_2025_14685_Fig2_HTML.jpg"/></fig>
</p></sec><sec id="Sec12"><title>Wavelet analysis and ARIMA-based time series modelling</title><p id="Par97">Wavelet analysis showed that CAP had an annual periodicity during the study period (Fig.&#160;<xref rid="Fig3" ref-type="fig">3</xref>). Studies have shown that CAP have 21&#8211;26 months periodicity, suggesting CAP cases attributed to all serotypes showed periodicity of two to three years. According to the global power spectrum, the 24-month periodicity of CAP was stronger than other viruses (Fig.&#160;<xref rid="Fig3" ref-type="fig">3</xref>A). After identifying, estimating, and diagnosing the model, the final optimal model was determined to be ARIMA (1,0,0) (0,0,0). Based on the ARIMA (1,0,0) (0,0,0) model, the projected trend of CAP incidence in Henan Province from November 2023 to December 2024 was calculated to indicate a gradual decline in cases (Fig.&#160;<xref rid="Fig3" ref-type="fig">3</xref>B). Table&#160;<xref rid="Tab1" ref-type="table">1</xref> in Supplementary Material 1 indicated that the simulation and prediction trends of CAP generated by this model were closely aligned with the actual observations, thereby validating the reliability of the developed SARIMA model in evaluating the epidemiological trends of CAP.</p><p id="Par98">
<fig id="Fig3" position="float" orientation="portrait"><label>Fig. 3</label><caption><p>Wavelet analysis and ARIMA-based time series modelling. The MATLAB software platform was employed for the purpose of performing Morlet wavelet transforms (<bold>A</bold>), with the objective of identifying and analyzing latent periodic patterns in time series data. The ARIMA model (<bold>B</bold>) was identified automatically using the expert modeler function of SPSS, which selected the most suitable ARIMA parameter combinations for the original dataset to ensure that the resulting model could reflect the dynamics of the data to the greatest extent possible.</p></caption><graphic id="d33e964" position="float" orientation="portrait" xlink:href="41598_2025_14685_Fig3_HTML.jpg"/></fig>
</p></sec><sec id="Sec13"><title>Pathogen detection of children with CAP in Henan Province from 2015 to 2023</title><p id="Par99">A total of 2000 children hospitalized with CAP were randomly selected from 2015 to 2023 with the aim of determining the distribution of pathogen species (Supplementary Material 1, Table&#160;2). A higher proportion of SCAP than non-SCAP was seen in males (51.5% vs. 40.1%, <italic toggle="yes">p</italic>&lt;0.01), Length of hospital median (10 vs. 8, <italic toggle="yes">p</italic>&lt;0.001). Among the enrolled patients, 75.0% (1499/2000) showed significant improvement at discharge, and no mortality occurred during the study period.</p><p id="Par100">Pathogen distribution patterns differed significantly between SCAP and non-SCAP cases across pediatric age groups. In infants&#8201;&lt; 1&#8201;year, viral-viral co-infection predominated in SCAP cases, while MP monoinfection was more frequent in non-SCAP cases. In children aged 1&#8211;2 years, bacterial co-infection increased in SCAP cases, whereas viral monoinfection rates rose in non-SCAP cases. Among 3&#8211;5-year-olds, bacterial-bacterial co-infection were more common in SCAP cases, while MP-bacterial co-infection prevailed in non-SCAP cases. For children aged 6&#8211;18 years, MP-viral co-infection dominated in SCAP cases, contrasting with viral-bacterial co-infection in non-SCAP cases (Fig.&#160;<xref rid="Fig4" ref-type="fig">4</xref>).</p><p id="Par101">Annual pathogen surveillance identified MP as the predominant pathogen. The detection rates ranged from 58.4 to 72.1%, and there was a significant increase in 2023 (72.1% compared to the pre-pandemic average of 63.8%). MP accounted for over 60% of monoinfections across all age groups. Secondary pathogens showed distinct temporal trends: RSV was the second most frequently detected pathogen in 2015&#8211;2017 (18.7&#8211;22.3%), followed by SP, which increased by 38% in 2018&#8211;2019 (from 15.2 to 16.8%) before declining to 6.3% after 2019. PIV detections increased during 2020&#8211;2021 (13.5&#8211;14.9%, compared to 2018&#8211;2019), while ADV emerged among the top five pathogens in 2022&#8211;2023 (8.7&#8211;11.2%) (Supplementary Material 1, Fig.&#160;<xref rid="Fig3" ref-type="fig">3</xref>).</p><p id="Par102">
<fig id="Fig4" position="float" orientation="portrait"><label>Fig. 4</label><caption><p>Pathogen detection of children with CAP in henan province from 2015 to 2023. Using laboratory-confirmed pathogen data, we analyzed co-infection patterns and pathogen distribution by year and severity (Non-SCAP/SCAP) in 2000 pediatric CAP cases. <italic toggle="yes">HRV</italic> rhinovirus, <italic toggle="yes">IV</italic> influenza virus, <italic toggle="yes">ADV</italic> adenovirus, <italic toggle="yes">PIV</italic> Parainfluenza virus, <italic toggle="yes">RSV</italic> Respiratory syncytial virus, <italic toggle="yes">SP</italic> Streptococcus pneumonia, <italic toggle="yes">HI</italic> Haemophilus influenza, <italic toggle="yes">MP</italic> Mycoplasma pneumonia, <italic toggle="yes">H</italic>. parainfluenzae, Haemophilus parainfluenzae, <italic toggle="yes">RV</italic> Rhinovirus.</p></caption><graphic id="d33e1026" position="float" orientation="portrait" xlink:href="41598_2025_14685_Fig4_HTML.jpg"/></fig>
</p></sec></sec><sec id="Sec14"><title>Discussion</title><p id="Par103">CAP represents one of the most prevalent severe infections in pediatric populations and is a significant contributor to hospitalization rates and mortality globally<sup><xref ref-type="bibr" rid="CR13">13</xref>&#8211;<xref ref-type="bibr" rid="CR15">15</xref></sup>. In recent years, the incidence of CAP has significantly increased, becoming a major public health concern. In particular, children over 3 years, particularly those aged 3 to 5, are at high-risk group for developing CAP<sup><xref ref-type="bibr" rid="CR16">16</xref>,<xref ref-type="bibr" rid="CR17">17</xref></sup>. These findings underscore the importance of implementing age-specific preventive strategies for preschool children and adolescents, considering their immunologically immature status and increased susceptibility to infectious diseases<sup><xref ref-type="bibr" rid="CR18">18</xref></sup>. Although the epidemiology of CAP in adults has been extensively characterized, pediatric data remain relatively limited. To address this knowledge gap, we performed a retrospective analysis of 23,459 CAP cases among children hospitalized at Children&#8217;s Hospital Affiliated to Zhengzhou University and Zhengzhou University&#8217;s Third Affiliated Hospital between 2015 and 2023, aiming to elucidate regional hospitalization patterns and epidemiological characteristics.</p><p id="Par104">Prior research on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 2019 (COVID-19) has underscored the pivotal influence of gender factor on susceptibility to viral infection, disease presentation, management, and treatment outcomes<sup><xref ref-type="bibr" rid="CR19">19</xref></sup>. The results of our investigation revealed a male-to-female ratio of 1.2:1. Kutty et al. exploration of MP in U.S. children hospitalized for community-acquired pneumonia uncovered a male-to-female ratio of 1.3:1<sup>9</sup>. A retrospective examination by Zhang et al. ascertained that the male-to-female ratio of hospitalized community-acquired pneumonia among children in Beijing was 1.2:1, and no significant disparities in gender distribution were detected either before or after the COVID-19 pandemic<sup><xref ref-type="bibr" rid="CR20">20</xref></sup>. The study also revealed that, on average, more cases of CAP requiring hospitalization were observed in men than in women over the years. This trend was consistently observed across both urban and rural age groups, indicating a higher proportion of reported cases involved men. This phenomenon can be attributed to several factors, including gender-specific immune responses and personality traits, lifestyle differences, activity levels, and pathogens exposure between men and women.</p><p id="Par105">Epidemiological analysis revealed CAP cases across all pediatric age groups, with the highest disease burden observed in school-aged children (6&#8211;18 years), followed by preschool children (3&#8211;5 years), toddlers (1&#8211;2 years), and infants (&lt;&#8201;1 year). A concerning upward trend was noted among 3&#8211;18&#160;year-olds in recent years (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001), accompanied by a significant increase in cases among children under two years of age.</p><p id="Par106">Pathogen analysis of 2,000 CAP cases identified Mycoplasma pneumonia (MP) as the predominant etiological agent. These findings aligned with previous reports, which demonstrated MP&#8217;s predominance in pediatric CAP, particularly among 5&#8211;9 year-olds, where it accounted for approximately 40% of cases<sup><xref ref-type="bibr" rid="CR21">21</xref></sup>. Cheng et al. identified the highest prevalence of MP infection among middle school-aged children with CAP in Beijing, which was epidemiologically associated with respiratory droplet transmission of the pathogen<sup><xref ref-type="bibr" rid="CR22">22</xref>,<xref ref-type="bibr" rid="CR23">23</xref></sup>.</p><p id="Par107">As a typical seasonal disease, CAP incidence peaks in winter and spring each year, and its epidemiological trend coincides with other respiratory infectious diseases such as MP, measles, and influenza<sup><xref ref-type="bibr" rid="CR24">24</xref></sup>. MATLAB&#8217;s wavelet analysis results show that there is a cyclical prevalence trend for CAP between 2019 and 2021. Outbreaks occur every two or three years. In particular, in 2023, a massive outbreak of MP spawned a surge in cases of CAP<sup><xref ref-type="bibr" rid="CR25">25</xref></sup>.</p><p id="Par108">Inconsistent with prior reports<sup><xref ref-type="bibr" rid="CR26">26</xref></sup>the incidence of Mycoplasma pneumonia single infection and co-infection are relatively high. Such co-infection typically had a rapid onset and a poor prognosis. Vaccination against Haemophilus influenzae type b (Hib), pneumococcus, measles and influenza were the most effective way to prevent pneumonia<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>. In developed countries, at least one-third of severe pneumonia cases and two-thirds of pneumonia-related deaths can be prevented by vaccination. As of 2015, pneumococcal conjugate vaccine (PCV), Hib vaccine and influenza vaccine were included in the national immunization schedules of 129, 192 and 102 Member States, respectively<sup><xref ref-type="bibr" rid="CR28">28</xref></sup>. Despite ongoing progress in the development of new antibiotics, steady progress in the development of pneumococcal and influenza vaccines and widespread vaccination, and the emergence of new diagnostic technologies, the incidence of CAP has shown an alarming increase year after year<sup><xref ref-type="bibr" rid="CR29">29</xref></sup>.</p><p id="Par109">The etiology of CAP varies with shifting pathogen prevalence. Our analysis revealed an oscillating but increasing trend for MP, while PIV and RSV declined over time. Although S. pneumonia is the leading cause of pediatric CAP, its high nasopharyngeal carriage rate (20&#8211;40%) in healthy children complicates microbiological diagnosis. To address this, our diagnostic framework required radiographic consolidation paired with systemic inflammation markers (CRP&#8201;&gt;&#8201;50&#160;mg/L or hypoxemia), supplemented by urinary antigen testing (for invasive pneumococcal antigens) and blood cultures to enhance specificity, as per IDSA/PIDS guidelines<sup><xref ref-type="bibr" rid="CR30">30</xref></sup>. Future studies incorporating quantitative PCR could further differentiate colonization from infection. Data from U.S. hospitals demonstrated significantly higher pediatric detection rates for PIV compared to adults (6.6% vs. 2.9%; <italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.001). Additionally, PIV-1 and PIV-2 showed biennial alternation patterns, while PIV-3 exhibited seasonal peaks during summer months<sup><xref ref-type="bibr" rid="CR31">31</xref></sup>.</p><p id="Par110">The global incidence of MP averaged 8.61% during 2017&#8211;2020. The implementation of non-pharmaceutical interventions (NPIs) for COVID-19 significantly reduced MP transmission, decreasing the incidence to 1.69% during 2020&#8211;2021. Despite the relaxation of NPIs, the incidence further declined to 0.70% during 2021&#8211;2022, potentially reflecting sustained public health improvements and residual effects of NPIs. Concurrently, the prevalence of other respiratory pathogens increased during this period<sup><xref ref-type="bibr" rid="CR32">32</xref></sup>.</p><p id="Par111">The COVID-19 pandemic has profoundly impacted the epidemiological characteristics of CAP. Monitoring data shows that the hospitalization rate of children with CAP dropped sharply by 54% in 2020, directly reflecting the inhibitory effect of NPIs on the transmission of respiratory pathogens. However, with the relaxation of epidemic prevention measures and the emergence of SARS-CoV-2 variants, the number of CAP cases rebounded significantly in 2021&#8211;2022, and the incidence rate among children even exceeded the pre-pandemic level. This phenomenon reveals the complex interaction between the &#8220;immunity debt&#8221; effect and the transformation of medical service models<sup><xref ref-type="bibr" rid="CR33">33</xref></sup>. Notably, our data revealed synchronous disruption of MP seasonality and co-infection dynamics, with epidemics peaking 3&#8211;5 months later than historical baselines. This resurgence culminated in 2023 with a 2.8-fold increase in MP detection rates, potentially reflecting waning herd immunity and the concurrent emergence of macrolide-resistant strains<sup><xref ref-type="bibr" rid="CR34">34</xref></sup>. Time-series projections anticipate continued epidemiological volatility, forecasting peak CAP incidence in late 2023 followed by seasonal attenuation through 2024. These findings underscore the need for adaptive surveillance systems to address post-pandemic epidemiological perturbations and antimicrobial resistance patterns.</p><p id="Par112">Our longitudinal analysis has revealed three major epidemiological trends. Firstly, MP has remained dominant, with its positive rate rebounding to 72.1% in 2023. This phenomenon is likely directly related to the decline in herd immunity levels caused by NPIs during the pandemic<sup><xref ref-type="bibr" rid="CR35">35</xref></sup>. Secondly, there have been dynamic changes in secondary pathogens: RSV was dominant from 2015 to 2017 (18.7&#8211;22.3%), but was then replaced by S. pneumonia from 2018 to 2019 (15.2&#8211;16.8%). With the widespread vaccination, the positive rate of the latter has significantly dropped to 6.3%. Notably, adenovirus has become one of the top five pathogens, and the co-infection rate with MP has increased six-fold since 2018. Thirdly, despite the disruptions caused by the pandemic, RSV has maintained a stable two-year epidemic cycle, highlighting the ecological adaptability of endemic respiratory viruses.</p><p id="Par113">The geographical distribution of respiratory diseases shows a clear urban-rural divide, with the age-standardized mortality rate for pneumonia following a pattern of higher rates in urban than in rural areas<sup><xref ref-type="bibr" rid="CR36">36</xref></sup>. This study revealed significantly higher CAP hospitalization rates in urban areas compared to rural areas over the past decade. Two key factors may account for this disparity: (1) pronounced differences in air quality between urban and rural environments, and (2) the location of the study hospital in an urban area, which improved healthcare accessibility for residents of Zhengzhou.</p><p id="Par114">This study has several limitations that warrant consideration. First, the retrospective design (2015&#8211;2023) may introduce recall bias, particularly regarding data from 2015 when the electronic medical record system was not fully operational. Second, etiological diagnosis was complicated by frequent viral-bacterial co-infection, limiting the precise attribution of pathogen-specific effects. Current diagnostic methodologies also face challenges in reliably distinguishing pathogenic from colonizing bacteria in respiratory specimens, which may confound the interpretation of results<sup><xref ref-type="bibr" rid="CR37">37</xref></sup>. Third, although the proportion of cases in each age group remained stable from 2015 to 2022, the number of cases in all age groups, especially among children aged 5 to 18, rose significantly in 2023. This might slightly distort the age-related trends, but the consistent increase across all age groups means that it does not affect the main conclusions. Finally, the data from the two tertiary hospitals in Zhengzhou mainly reflect severe or complex cases requiring hospitalization. As provincial referral centers, these institutions underestimate the mild cases managed in primary care settings, and geographical referral bias may result in an overrepresentation of patients from the surrounding areas of Zhengzhou.</p></sec><sec id="Sec15"><title>Conclusion</title><p id="Par115">In summary, the incidence of CAP in children in Henan Province shows a seasonal upward trend. The primary cause of infection is identified as MP, and it is often combined with various bacteria and viruses in different age groups.</p></sec><sec id="Sec16" sec-type="supplementary-material"><title>Supplementary Information</title><p>Below is the link to the electronic supplementary material.</p><p>
<supplementary-material content-type="local-data" id="MOESM1" position="float" orientation="portrait"><media xlink:href="41598_2025_14685_MOESM1_ESM.doc" position="float" orientation="portrait"><caption><p>Supplementary Material 1</p></caption></media></supplementary-material>
</p></sec></body><back><fn-group><fn><p><bold>Publisher&#8217;s note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><title>Acknowledgements</title><p>The authors are grateful to the data collectors and study participants.</p></ack><notes notes-type="author-contribution"><title>Author contributions</title><p>T.L. and Y.J.: Conceptualization; T.L.: methodology, data curation, writing&#8212;original draft preparation; T.L. and S.C.: software, supervision, writing&#8212;review and editing; S.C., Z.L., S.H., Y.Y., Y.Z., F.W., D.F., and Y.S.: resources, project administration; Y.J., Z.P. and F.W.: funding acquisition; Y.Y.: validation; Y.Z. and Y.S.: formal analysis; Z.L.: investigation; S.C.: visualization. All authors have read and agreed to the published version of the manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>This work was supported by China Postdoctoral Science Foundation (No. 2024T170246, No. 2024M750815), supported by the Open Grant from the Pingyuan Laboratory (No. 2023PY-OP-0202), supported by Open Project of Henan Province Engineering Research Center of Diagnosis and Treatment of Pediatric Infection and Critical Care (No. ERC202302), supported by the Zhengzhou Science and Technology Beneficiary Program Project (No. 2022KJHM0004), supported by the Open Project of Key Laboratory of Infection and Immunity of Anhui Higher Education Institutes (No. I&amp;I-2024-R01), supported by the Open Project of Key Laboratory of Children&#8217;s Disease Research in Guangxi&#8217;s Colleges and Universities (No. GXCDR202401), supported by Program for Innovative Talents in Higher Education Institutions of Henan Province (No. 25HASTIT055), and supported by Outstanding Youth Science Foundation of Henan Province (No. 252300421122), and supported by Jointly-built Project of Henan Province Medical Science and Technology Research Program (LHGJ20210470). The funders had no role in study design, data collection and analysis, the decision to publish, or preparation of the manuscript.</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>The data sets used and/or analyzed during the current study are available from the corresponding author upon reasonable request.</p></notes><notes><title>Declarations</title><notes id="FPar2" notes-type="COI-statement"><title>Competing interests</title><p id="Par117">The authors declare no competing interests.</p></notes><notes id="FPar1"><title>Ethics approval and consent to participate</title><p id="Par116">The study received approval from the Life Sciences Institutional Review Board of Zhengzhou University (ZZUIRB2023-180). Written informed consent was obtained from the parents or guardians of the study participants. Research involving human research participants must have been performed in accordance with the Declaration of Helsinki.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>le Roux</surname><given-names>DM</given-names></name><name name-style="western"><surname>Myer</surname><given-names>L</given-names></name><name name-style="western"><surname>Nicol</surname><given-names>MP</given-names></name><name name-style="western"><surname>Zar</surname><given-names>HJ</given-names></name></person-group><article-title>Incidence and severity of childhood pneumonia in the first year of life in a South African birth cohort: the Drakenstein child health study</article-title><source>Lancet Glob Health</source><year>2015</year><volume>3</volume><fpage>e95</fpage><lpage>e103</lpage><pub-id pub-id-type="doi">10.1016/s2214-109x(14)70360-2</pub-id><pub-id pub-id-type="pmid">25617203</pub-id></element-citation><mixed-citation id="mc-CR1" publication-type="journal">le Roux, D. M., Myer, L., Nicol, M. P. &amp; Zar, H. J. Incidence and severity of childhood pneumonia in the first year of life in a South African birth cohort: the Drakenstein child health study. <italic toggle="yes">Lancet Glob Health</italic>. <bold>3</bold>, e95&#8211;e103. 10.1016/s2214-109x(14)70360-2 (2015).<pub-id pub-id-type="pmid">25617203</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S2214-109X(14)70360-2</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Quan</surname><given-names>TP</given-names></name><etal/></person-group><article-title>Increasing burden of community-acquired pneumonia leading to hospitalisation, 1998&#8211;2014</article-title><source>Thorax</source><year>2016</year><volume>71</volume><fpage>535</fpage><lpage>542</lpage><pub-id pub-id-type="doi">10.1136/thoraxjnl-2015-207688</pub-id><pub-id pub-id-type="pmid">26888780</pub-id><pub-id pub-id-type="pmcid">PMC4893127</pub-id></element-citation><mixed-citation id="mc-CR2" publication-type="journal">Quan, T. P. et al. Increasing burden of community-acquired pneumonia leading to hospitalisation, 1998&#8211;2014. <italic toggle="yes">Thorax</italic><bold>71</bold>, 535&#8211;542. 10.1136/thoraxjnl-2015-207688 (2016).<pub-id pub-id-type="pmid">26888780</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/thoraxjnl-2015-207688</pub-id><pub-id pub-id-type="pmcid">PMC4893127</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Adamu</surname><given-names>AL</given-names></name><etal/></person-group><article-title>The cost of illness for childhood clinical pneumonia and invasive pneumococcal disease in Nigeria</article-title><source>BMJ Glob Health</source><year>2022</year><pub-id pub-id-type="doi">10.1136/bmjgh-2021-007080</pub-id><pub-id pub-id-type="pmid">35101861</pub-id><pub-id pub-id-type="pmcid">PMC8804652</pub-id></element-citation><mixed-citation id="mc-CR3" publication-type="journal">Adamu, A. L. et al. The cost of illness for childhood clinical pneumonia and invasive pneumococcal disease in Nigeria. <italic toggle="yes">BMJ Glob Health</italic>10.1136/bmjgh-2021-007080 (2022).<pub-id pub-id-type="pmid">35101861</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bmjgh-2021-007080</pub-id><pub-id pub-id-type="pmcid">PMC8804652</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Qin</surname><given-names>T</given-names></name><etal/></person-group><article-title>Incidence, etiology, and environmental risk factors of Community-Acquired pneumonia requiring hospitalization in china: A 3-Year, prospective, Age-Stratified, multicenter Case-Control study</article-title><source>Open. Forum Infect. Dis.</source><year>2021</year><volume>8</volume><fpage>ofab499</fpage><pub-id pub-id-type="doi">10.1093/ofid/ofab499</pub-id><pub-id pub-id-type="pmid">35548172</pub-id><pub-id pub-id-type="pmcid">PMC8522381</pub-id></element-citation><mixed-citation id="mc-CR4" publication-type="journal">Qin, T. et al. Incidence, etiology, and environmental risk factors of Community-Acquired pneumonia requiring hospitalization in china: A 3-Year, prospective, Age-Stratified, multicenter Case-Control study. <italic toggle="yes">Open. Forum Infect. Dis.</italic><bold>8</bold>, ofab499. 10.1093/ofid/ofab499 (2021).<pub-id pub-id-type="pmid">35548172</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/ofid/ofab499</pub-id><pub-id pub-id-type="pmcid">PMC8522381</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hibberd</surname><given-names>J</given-names></name><name name-style="western"><surname>Mistry</surname><given-names>R</given-names></name></person-group><article-title>COVID-19, primary care, and paediatrics: winter is coming</article-title><source>Br. J. Gen. Pract.</source><year>2020</year><volume>70</volume><fpage>450</fpage><pub-id pub-id-type="doi">10.3399/bjgp20X712385</pub-id><pub-id pub-id-type="pmid">32855134</pub-id><pub-id pub-id-type="pmcid">PMC7449444</pub-id></element-citation><mixed-citation id="mc-CR5" publication-type="journal">Hibberd, J. &amp; Mistry, R. COVID-19, primary care, and paediatrics: winter is coming. <italic toggle="yes">Br. J. Gen. Pract.</italic><bold>70</bold>, 450. 10.3399/bjgp20X712385 (2020).<pub-id pub-id-type="pmid">32855134</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3399/bjgp20X712385</pub-id><pub-id pub-id-type="pmcid">PMC7449444</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Katz</surname><given-names>SE</given-names></name><name name-style="western"><surname>Williams</surname><given-names>DJ</given-names></name></person-group><article-title>Pediatric Community-Acquired pneumonia in the united states: changing epidemiology, diagnostic and therapeutic challenges, and areas for future research</article-title><source>Infect. Dis. Clin. North. Am.</source><year>2018</year><volume>32</volume><fpage>47</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1016/j.idc.2017.11.002</pub-id><pub-id pub-id-type="pmid">29269189</pub-id><pub-id pub-id-type="pmcid">PMC5801082</pub-id></element-citation><mixed-citation id="mc-CR6" publication-type="journal">Katz, S. E. &amp; Williams, D. J. Pediatric Community-Acquired pneumonia in the united states: changing epidemiology, diagnostic and therapeutic challenges, and areas for future research. <italic toggle="yes">Infect. Dis. Clin. North. Am.</italic><bold>32</bold>, 47&#8211;63. 10.1016/j.idc.2017.11.002 (2018).<pub-id pub-id-type="pmid">29269189</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.idc.2017.11.002</pub-id><pub-id pub-id-type="pmcid">PMC5801082</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grijalva</surname><given-names>CG</given-names></name></person-group><article-title>What fraction of adult Community-Acquired pneumonia is caused by the pneumococcus?? New insights from Spain</article-title><source>Clin. Infect. Dis.</source><year>2021</year><volume>73</volume><fpage>1086</fpage><lpage>1088</lpage><pub-id pub-id-type="doi">10.1093/cid/ciab314</pub-id><pub-id pub-id-type="pmid">33851210</pub-id><pub-id pub-id-type="pmcid">PMC8442783</pub-id></element-citation><mixed-citation id="mc-CR7" publication-type="journal">Grijalva, C. G. What fraction of adult Community-Acquired pneumonia is caused by the pneumococcus?? New insights from Spain. <italic toggle="yes">Clin. Infect. Dis.</italic><bold>73</bold>, 1086&#8211;1088. 10.1093/cid/ciab314 (2021).<pub-id pub-id-type="pmid">33851210</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/cid/ciab314</pub-id><pub-id pub-id-type="pmcid">PMC8442783</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>YC</given-names></name><name name-style="western"><surname>Hsu</surname><given-names>WY</given-names></name><name name-style="western"><surname>Chang</surname><given-names>TH</given-names></name></person-group><article-title>Macrolide-Resistant Mycoplasma pneumonia infections in pediatric Community-Acquired pneumonia</article-title><source>Emerg. Infect. Dis.</source><year>2020</year><volume>26</volume><fpage>1382</fpage><lpage>1391</lpage><pub-id pub-id-type="doi">10.3201/eid2607.200017</pub-id><pub-id pub-id-type="pmid">32568052</pub-id><pub-id pub-id-type="pmcid">PMC7323531</pub-id></element-citation><mixed-citation id="mc-CR8" publication-type="journal">Chen, Y. C., Hsu, W. Y. &amp; Chang, T. H. Macrolide-Resistant Mycoplasma pneumonia infections in pediatric Community-Acquired pneumonia. <italic toggle="yes">Emerg. Infect. Dis.</italic><bold>26</bold>, 1382&#8211;1391. 10.3201/eid2607.200017 (2020).<pub-id pub-id-type="pmid">32568052</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3201/eid2607.200017</pub-id><pub-id pub-id-type="pmcid">PMC7323531</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kutty</surname><given-names>PK</given-names></name><etal/></person-group><article-title>Mycoplasma pneumonia among children hospitalized with Community-acquired pneumonia</article-title><source>Clin. Infect. Dis.</source><year>2019</year><volume>68</volume><fpage>5</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1093/cid/ciy419</pub-id><pub-id pub-id-type="pmid">29788037</pub-id><pub-id pub-id-type="pmcid">PMC6552676</pub-id></element-citation><mixed-citation id="mc-CR9" publication-type="journal">Kutty, P. K. et al. Mycoplasma pneumonia among children hospitalized with Community-acquired pneumonia. <italic toggle="yes">Clin. Infect. Dis.</italic><bold>68</bold>, 5&#8211;12. 10.1093/cid/ciy419 (2019).<pub-id pub-id-type="pmid">29788037</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/cid/ciy419</pub-id><pub-id pub-id-type="pmcid">PMC6552676</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bradley</surname><given-names>JS</given-names></name><etal/></person-group><article-title>The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the pediatric infectious diseases society and the infectious diseases society of America</article-title><source>Clin. Infect. Dis.</source><year>2011</year><volume>53</volume><fpage>e25</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1093/cid/cir531</pub-id><pub-id pub-id-type="pmid">21880587</pub-id><pub-id pub-id-type="pmcid">PMC7107838</pub-id></element-citation><mixed-citation id="mc-CR10" publication-type="journal">Bradley, J. S. et al. The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the pediatric infectious diseases society and the infectious diseases society of America. <italic toggle="yes">Clin. Infect. Dis.</italic><bold>53</bold>, e25&#8211;76. 10.1093/cid/cir531 (2011).<pub-id pub-id-type="pmid">21880587</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/cid/cir531</pub-id><pub-id pub-id-type="pmcid">PMC7107838</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><mixed-citation publication-type="other"><italic toggle="yes">Pocket Book of Hospital Care for Children: Guidelines for the Management of Common Childhood Illnesses</italic> (World Health Organization) Copyright &#169; (World Health Organization, 2013).<pub-id pub-id-type="pmid">24006557</pub-id></mixed-citation></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>ArunKumar</surname><given-names>KE</given-names></name><etal/></person-group><article-title>Forecasting the dynamics of cumulative COVID-19 cases (confirmed, recovered and deaths) for top-16 countries using statistical machine learning models: Auto-Regressive integrated moving average (ARIMA) and seasonal Auto-Regressive integrated moving average (SARIMA)</article-title><source>Appl. Soft Comput.</source><year>2021</year><volume>103</volume><fpage>107161</fpage><pub-id pub-id-type="doi">10.1016/j.asoc.2021.107161</pub-id><pub-id pub-id-type="pmid">33584158</pub-id><pub-id pub-id-type="pmcid">PMC7869631</pub-id></element-citation><mixed-citation id="mc-CR12" publication-type="journal">ArunKumar, K. E. et al. Forecasting the dynamics of cumulative COVID-19 cases (confirmed, recovered and deaths) for top-16 countries using statistical machine learning models: Auto-Regressive integrated moving average (ARIMA) and seasonal Auto-Regressive integrated moving average (SARIMA). <italic toggle="yes">Appl. Soft Comput.</italic><bold>103</bold>, 107161. 10.1016/j.asoc.2021.107161 (2021).<pub-id pub-id-type="pmid">33584158</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.asoc.2021.107161</pub-id><pub-id pub-id-type="pmcid">PMC7869631</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jain</surname><given-names>S</given-names></name><etal/></person-group><article-title>Community-acquired pneumonia requiring hospitalization among U.S. Children</article-title><source>N Engl. J. Med.</source><year>2015</year><volume>372</volume><fpage>835</fpage><lpage>845</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1405870</pub-id><pub-id pub-id-type="pmid">25714161</pub-id><pub-id pub-id-type="pmcid">PMC4697461</pub-id></element-citation><mixed-citation id="mc-CR13" publication-type="journal">Jain, S. et al. Community-acquired pneumonia requiring hospitalization among U.S. Children. <italic toggle="yes">N Engl. J. Med.</italic><bold>372</bold>, 835&#8211;845. 10.1056/NEJMoa1405870 (2015).<pub-id pub-id-type="pmid">25714161</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1056/NEJMoa1405870</pub-id><pub-id pub-id-type="pmcid">PMC4697461</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grudzinska</surname><given-names>FS</given-names></name></person-group><article-title>Moving mountains in community-acquired pneumonia: stone by stone we progress</article-title><source>Thorax</source><year>2023</year><volume>78</volume><fpage>1161</fpage><lpage>1162</lpage><pub-id pub-id-type="doi">10.1136/thorax-2023-220570</pub-id><pub-id pub-id-type="pmid">37620047</pub-id></element-citation><mixed-citation id="mc-CR14" publication-type="journal">Grudzinska, F. S. Moving mountains in community-acquired pneumonia: stone by stone we progress. <italic toggle="yes">Thorax</italic><bold>78</bold>, 1161&#8211;1162. 10.1136/thorax-2023-220570 (2023).<pub-id pub-id-type="pmid">37620047</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/thorax-2023-220570</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vlachopoulos</surname><given-names>CV</given-names></name><name name-style="western"><surname>Terentes-Printzios</surname><given-names>DG</given-names></name><name name-style="western"><surname>Aznaouridis</surname><given-names>KA</given-names></name><name name-style="western"><surname>Pietri</surname><given-names>PG</given-names></name><name name-style="western"><surname>Stefanadis</surname><given-names>CI</given-names></name></person-group><article-title>Association between Pneumococcal vaccination and cardiovascular outcomes: a systematic review and meta-analysis of cohort studies</article-title><source>Eur. J. Prev. Cardiol.</source><year>2015</year><volume>22</volume><fpage>1185</fpage><lpage>1199</lpage><pub-id pub-id-type="doi">10.1177/2047487314549512</pub-id><pub-id pub-id-type="pmid">25252595</pub-id></element-citation><mixed-citation id="mc-CR15" publication-type="journal">Vlachopoulos, C. V., Terentes-Printzios, D. G., Aznaouridis, K. A., Pietri, P. G. &amp; Stefanadis, C. I. Association between Pneumococcal vaccination and cardiovascular outcomes: a systematic review and meta-analysis of cohort studies. <italic toggle="yes">Eur. J. Prev. Cardiol.</italic><bold>22</bold>, 1185&#8211;1199. 10.1177/2047487314549512 (2015).<pub-id pub-id-type="pmid">25252595</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/2047487314549512</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>ZJ</given-names></name><etal/></person-group><article-title>Etiological and epidemiological features of acute respiratory infections in China</article-title><source>Nat. Commun.</source><year>2021</year><volume>12</volume><fpage>5026</fpage><pub-id pub-id-type="doi">10.1038/s41467-021-25120-6</pub-id><pub-id pub-id-type="pmid">34408158</pub-id><pub-id pub-id-type="pmcid">PMC8373954</pub-id></element-citation><mixed-citation id="mc-CR16" publication-type="journal">Li, Z. J. et al. Etiological and epidemiological features of acute respiratory infections in China. <italic toggle="yes">Nat. Commun.</italic><bold>12</bold>, 5026. 10.1038/s41467-021-25120-6 (2021).<pub-id pub-id-type="pmid">34408158</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41467-021-25120-6</pub-id><pub-id pub-id-type="pmcid">PMC8373954</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wallihan</surname><given-names>R</given-names></name><name name-style="western"><surname>Ramilo</surname><given-names>O</given-names></name></person-group><article-title>Community-acquired pneumonia in children: current challenges and future directions</article-title><source>J. Infect.</source><year>2014</year><volume>69</volume><issue>Suppl 1</issue><fpage>87</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1016/j.jinf.2014.07.021</pub-id><pub-id pub-id-type="pmid">25264163</pub-id></element-citation><mixed-citation id="mc-CR17" publication-type="journal">Wallihan, R. &amp; Ramilo, O. Community-acquired pneumonia in children: current challenges and future directions. <italic toggle="yes">J. Infect.</italic><bold>69</bold> (Suppl 1), 87&#8211;90. 10.1016/j.jinf.2014.07.021 (2014).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jinf.2014.07.021</pub-id><pub-id pub-id-type="pmid">25264163</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kharbanda</surname><given-names>EO</given-names></name><name name-style="western"><surname>Lee</surname><given-names>GM</given-names></name><name name-style="western"><surname>Koenigs</surname><given-names>L</given-names></name></person-group><article-title>Financing vaccines for adolescents: a position paper of the society for adolescent health and medicine</article-title><source>J. Adolesc. Health</source><year>2011</year><volume>48</volume><fpage>320</fpage><lpage>321</lpage><pub-id pub-id-type="doi">10.1016/j.jadohealth.2010.12.025</pub-id><pub-id pub-id-type="pmid">21338909</pub-id></element-citation><mixed-citation id="mc-CR18" publication-type="journal">Kharbanda, E. O., Lee, G. M. &amp; Koenigs, L. Financing vaccines for adolescents: a position paper of the society for adolescent health and medicine. <italic toggle="yes">J. Adolesc. Health</italic>. <bold>48</bold>, 320&#8211;321. 10.1016/j.jadohealth.2010.12.025 (2011).<pub-id pub-id-type="pmid">21338909</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jadohealth.2010.12.025</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><etal/></person-group><article-title>Mycoplasma pneumonia triggers pneumonia epidemic in autumn and winter in beijing: a multicentre, population-based epidemiological study between 2015 and 2020</article-title><source>Emerg. Microbes Infect.</source><year>2022</year><volume>11</volume><fpage>1508</fpage><lpage>1517</lpage><pub-id pub-id-type="doi">10.1080/22221751.2022.2078228</pub-id><pub-id pub-id-type="pmid">35582916</pub-id><pub-id pub-id-type="pmcid">PMC9176688</pub-id></element-citation><mixed-citation id="mc-CR19" publication-type="journal">Wang, X. et al. Mycoplasma pneumonia triggers pneumonia epidemic in autumn and winter in beijing: a multicentre, population-based epidemiological study between 2015 and 2020. <italic toggle="yes">Emerg. Microbes Infect.</italic><bold>11</bold>, 1508&#8211;1517. 10.1080/22221751.2022.2078228 (2022).<pub-id pub-id-type="pmid">35582916</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/22221751.2022.2078228</pub-id><pub-id pub-id-type="pmcid">PMC9176688</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>LN</given-names></name><name name-style="western"><surname>Cao</surname><given-names>L</given-names></name><name name-style="western"><surname>Meng</surname><given-names>LH</given-names></name></person-group><article-title>Pathogenic changes of community-acquired pneumonia in a children&#8217;s hospital in beijing, China before and after COVID-19 onset: a retrospective study</article-title><source>World J. Pediatr.</source><year>2022</year><volume>18</volume><fpage>746</fpage><lpage>752</lpage><pub-id pub-id-type="doi">10.1007/s12519-022-00592-8</pub-id><pub-id pub-id-type="pmid">35994171</pub-id><pub-id pub-id-type="pmcid">PMC9395926</pub-id></element-citation><mixed-citation id="mc-CR20" publication-type="journal">Zhang, L. N., Cao, L. &amp; Meng, L. H. Pathogenic changes of community-acquired pneumonia in a children&#8217;s hospital in beijing, China before and after COVID-19 onset: a retrospective study. <italic toggle="yes">World J. Pediatr.</italic><bold>18</bold>, 746&#8211;752. 10.1007/s12519-022-00592-8 (2022).<pub-id pub-id-type="pmid">35994171</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s12519-022-00592-8</pub-id><pub-id pub-id-type="pmcid">PMC9395926</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>K</given-names></name><etal/></person-group><article-title>Clinical symptoms and signs for the diagnosis of Mycoplasma pneumonia in children and adolescents with community-acquired pneumonia</article-title><source>Cochrane Database Syst. Rev.</source><year>2012</year><pub-id pub-id-type="doi">10.1002/14651858.CD009175.pub2</pub-id><pub-id pub-id-type="pmid">23076954</pub-id><pub-id pub-id-type="pmcid">PMC7117561</pub-id></element-citation><mixed-citation id="mc-CR21" publication-type="journal">Wang, K. et al. Clinical symptoms and signs for the diagnosis of Mycoplasma pneumonia in children and adolescents with community-acquired pneumonia. <italic toggle="yes">Cochrane Database Syst. Rev.</italic>10.1002/14651858.CD009175.pub2 (2012).<pub-id pub-id-type="pmid">23076954</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/14651858.CD009175.pub2</pub-id><pub-id pub-id-type="pmcid">PMC7117561</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>J</given-names></name><etal/></person-group><article-title>Mycoplasma pneumonia among Chinese outpatient children with mild respiratory tract infections during the coronavirus disease 2019 pandemic</article-title><source>Microbiol. Spectr.</source><year>2022</year><volume>10</volume><fpage>e0155021</fpage><pub-id pub-id-type="doi">10.1128/spectrum.01550-21</pub-id><pub-id pub-id-type="pmid">35138173</pub-id><pub-id pub-id-type="pmcid">PMC8826743</pub-id></element-citation><mixed-citation id="mc-CR22" publication-type="journal">Chen, J. et al. Mycoplasma pneumonia among Chinese outpatient children with mild respiratory tract infections during the coronavirus disease 2019 pandemic. <italic toggle="yes">Microbiol. Spectr.</italic><bold>10</bold>, e0155021. 10.1128/spectrum.01550-21 (2022).<pub-id pub-id-type="pmid">35138173</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/spectrum.01550-21</pub-id><pub-id pub-id-type="pmcid">PMC8826743</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cheng</surname><given-names>Y</given-names></name><etal/></person-group><article-title>The prevalence of Mycoplasma pneumonia among children in Beijing before and during the COVID-19 pandemic</article-title><source>Front. Cell. Infect. Microbiol.</source><year>2022</year><volume>12</volume><fpage>854505</fpage><pub-id pub-id-type="doi">10.3389/fcimb.2022.854505</pub-id><pub-id pub-id-type="pmid">35573799</pub-id><pub-id pub-id-type="pmcid">PMC9103471</pub-id></element-citation><mixed-citation id="mc-CR23" publication-type="journal">Cheng, Y. et al. The prevalence of Mycoplasma pneumonia among children in Beijing before and during the COVID-19 pandemic. <italic toggle="yes">Front. Cell. Infect. Microbiol.</italic><bold>12</bold>, 854505. 10.3389/fcimb.2022.854505 (2022).<pub-id pub-id-type="pmid">35573799</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fcimb.2022.854505</pub-id><pub-id pub-id-type="pmcid">PMC9103471</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gong</surname><given-names>C</given-names></name><etal/></person-group><article-title>Increase of respiratory illnesses among children in Beijing, China, during the autumn and winter of 2023</article-title><source>Euro. Surveill</source><year>2024</year><pub-id pub-id-type="doi">10.2807/1560-7917.Es.2024.29.2.2300704</pub-id><pub-id pub-id-type="pmid">38214078</pub-id><pub-id pub-id-type="pmcid">PMC10785205</pub-id></element-citation><mixed-citation id="mc-CR24" publication-type="journal">Gong, C. et al. Increase of respiratory illnesses among children in Beijing, China, during the autumn and winter of 2023. <italic toggle="yes">Euro. Surveill</italic>10.2807/1560-7917.Es.2024.29.2.2300704 (2024).<pub-id pub-id-type="pmid">38214078</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2807/1560-7917.ES.2024.29.2.2300704</pub-id><pub-id pub-id-type="pmcid">PMC10785205</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Israelsen</surname><given-names>SB</given-names></name><etal/></person-group><article-title>Short-course antibiotic therapy for hospitalized patients with early clinical response in community-acquired pneumonia: a multicentre cohort study</article-title><source>Clin. Microbiol. Infect.</source><year>2023</year><volume>29</volume><fpage>54</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1016/j.cmi.2022.08.004</pub-id><pub-id pub-id-type="pmid">35988851</pub-id></element-citation><mixed-citation id="mc-CR25" publication-type="journal">Israelsen, S. B. et al. Short-course antibiotic therapy for hospitalized patients with early clinical response in community-acquired pneumonia: a multicentre cohort study. <italic toggle="yes">Clin. Microbiol. Infect.</italic><bold>29</bold>, 54&#8211;60. 10.1016/j.cmi.2022.08.004 (2023).<pub-id pub-id-type="pmid">35988851</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cmi.2022.08.004</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>26 Juv&#233;n</surname><given-names>T</given-names></name><name name-style="western"><surname>Mertsola</surname><given-names>J</given-names></name><name name-style="western"><surname>Waris</surname><given-names>M</given-names></name><name name-style="western"><surname>Leinonen</surname><given-names>M</given-names></name><name name-style="western"><surname>Ruuskanen</surname><given-names>O</given-names></name></person-group><article-title>Clinical response to antibiotic therapy for community-acquired pneumonia</article-title><source>Eur. J. Pediatr.</source><year>2004</year><volume>163</volume><fpage>140</fpage><lpage>144</lpage><pub-id pub-id-type="doi">10.1007/s00431-003-1397-2</pub-id><pub-id pub-id-type="pmid">14758544</pub-id><pub-id pub-id-type="pmcid">PMC7086919</pub-id></element-citation><mixed-citation id="mc-CR26" publication-type="journal">26 Juv&#233;n, T., Mertsola, J., Waris, M., Leinonen, M. &amp; Ruuskanen, O. Clinical response to antibiotic therapy for community-acquired pneumonia. <italic toggle="yes">Eur. J. Pediatr.</italic><bold>163</bold>, 140&#8211;144. 10.1007/s00431-003-1397-2 (2004).<pub-id pub-id-type="pmid">14758544</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00431-003-1397-2</pub-id><pub-id pub-id-type="pmcid">PMC7086919</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bhutta</surname><given-names>ZA</given-names></name><name name-style="western"><surname>Das</surname><given-names>JK</given-names></name></person-group><article-title>Global burden of childhood diarrhea and pneumonia: what can and should be done?</article-title><source>Pediatrics</source><year>2013</year><volume>131</volume><fpage>634</fpage><lpage>636</lpage><pub-id pub-id-type="doi">10.1542/peds.2012-3737</pub-id><pub-id pub-id-type="pmid">23509166</pub-id></element-citation><mixed-citation id="mc-CR27" publication-type="journal">Bhutta, Z. A. &amp; Das, J. K. Global burden of childhood diarrhea and pneumonia: what can and should be done? <italic toggle="yes">Pediatrics</italic><bold>131</bold>, 634&#8211;636. 10.1542/peds.2012-3737 (2013).<pub-id pub-id-type="pmid">23509166</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1542/peds.2012-3737</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ning</surname><given-names>G</given-names></name><etal/></person-group><article-title>The etiology of community-acquired pneumonia among children under 5 years of age in Mainland china, 2001&#8211;2015: A systematic review</article-title><source>Hum. Vaccin Immunother</source><year>2017</year><volume>13</volume><fpage>2742</fpage><lpage>2750</lpage><pub-id pub-id-type="doi">10.1080/21645515.2017.1371381</pub-id><pub-id pub-id-type="pmid">28922613</pub-id><pub-id pub-id-type="pmcid">PMC5703373</pub-id></element-citation><mixed-citation id="mc-CR28" publication-type="journal">Ning, G. et al. The etiology of community-acquired pneumonia among children under 5 years of age in Mainland china, 2001&#8211;2015: A systematic review. <italic toggle="yes">Hum. Vaccin Immunother</italic>. <bold>13</bold>, 2742&#8211;2750. 10.1080/21645515.2017.1371381 (2017).<pub-id pub-id-type="pmid">28922613</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/21645515.2017.1371381</pub-id><pub-id pub-id-type="pmcid">PMC5703373</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Castiglia</surname><given-names>P</given-names></name></person-group><article-title>Recommendations for Pneumococcal immunization outside routine childhood immunization programs in Western Europe</article-title><source>Adv. Ther.</source><year>2014</year><volume>31</volume><fpage>1011</fpage><lpage>1044</lpage><pub-id pub-id-type="doi">10.1007/s12325-014-0157-1</pub-id><pub-id pub-id-type="pmid">25300593</pub-id><pub-id pub-id-type="pmcid">PMC4209094</pub-id></element-citation><mixed-citation id="mc-CR29" publication-type="journal">Castiglia, P. Recommendations for Pneumococcal immunization outside routine childhood immunization programs in Western Europe. <italic toggle="yes">Adv. Ther.</italic><bold>31</bold>, 1011&#8211;1044. 10.1007/s12325-014-0157-1 (2014).<pub-id pub-id-type="pmid">25300593</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s12325-014-0157-1</pub-id><pub-id pub-id-type="pmcid">PMC4209094</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van der Poll</surname><given-names>T</given-names></name><name name-style="western"><surname>Opal</surname><given-names>SM</given-names></name></person-group><article-title>Pathogenesis, treatment, and prevention of Pneumococcal pneumonia</article-title><source>Lancet</source><year>2009</year><volume>374</volume><fpage>1543</fpage><lpage>1556</lpage><pub-id pub-id-type="doi">10.1016/s0140-6736(09)61114-4</pub-id><pub-id pub-id-type="pmid">19880020</pub-id></element-citation><mixed-citation id="mc-CR30" publication-type="journal">van der Poll, T. &amp; Opal, S. M. Pathogenesis, treatment, and prevention of Pneumococcal pneumonia. <italic toggle="yes">Lancet</italic><bold>374</bold>, 1543&#8211;1556. 10.1016/s0140-6736(09)61114-4 (2009).<pub-id pub-id-type="pmid">19880020</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0140-6736(09)61114-4</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Howard</surname><given-names>LM</given-names></name><etal/></person-group><article-title>Parainfluenza virus types 1&#8211;3 infections among children and adults hospitalized with Community-acquired pneumonia</article-title><source>Clin. Infect. Dis.</source><year>2021</year><volume>73</volume><fpage>e4433</fpage><lpage>e4443</lpage><pub-id pub-id-type="doi">10.1093/cid/ciaa973</pub-id><pub-id pub-id-type="pmid">32681645</pub-id><pub-id pub-id-type="pmcid">PMC8662767</pub-id></element-citation><mixed-citation id="mc-CR31" publication-type="journal">Howard, L. M. et al. Parainfluenza virus types 1&#8211;3 infections among children and adults hospitalized with Community-acquired pneumonia. <italic toggle="yes">Clin. Infect. Dis.</italic><bold>73</bold>, e4433&#8211;e4443. 10.1093/cid/ciaa973 (2021).<pub-id pub-id-type="pmid">32681645</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/cid/ciaa973</pub-id><pub-id pub-id-type="pmcid">PMC8662767</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Meyer Sauteur</surname><given-names>PM</given-names></name></person-group><article-title>Mycoplasma pneumonia: gone forever?</article-title><source>Lancet Microbe</source><year>2023</year><volume>4</volume><fpage>e763</fpage><pub-id pub-id-type="doi">10.1016/s2666-5247(23)00182-9</pub-id><pub-id pub-id-type="pmid">37393927</pub-id></element-citation><mixed-citation id="mc-CR32" publication-type="journal">Meyer Sauteur, P. M. (ed Beeton, M. L.) Mycoplasma pneumonia: gone forever? <italic toggle="yes">Lancet Microbe</italic><bold>4</bold> e763 10.1016/s2666-5247(23)00182-9 (2023).<pub-id pub-id-type="pmid">37393927</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S2666-5247(23)00182-9</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cohen</surname><given-names>R</given-names></name><etal/></person-group><article-title>Pediatric infectious disease group (GPIP) position paper on the immune debt of the COVID-19 pandemic in childhood, how can we fill the immunity gap?</article-title><source>Infect. Dis. Now</source><year>2021</year><volume>51</volume><fpage>418</fpage><lpage>423</lpage><pub-id pub-id-type="doi">10.1016/j.idnow.2021.05.004</pub-id><pub-id pub-id-type="pmid">33991720</pub-id><pub-id pub-id-type="pmcid">PMC8114587</pub-id></element-citation><mixed-citation id="mc-CR33" publication-type="journal">Cohen, R. et al. Pediatric infectious disease group (GPIP) position paper on the immune debt of the COVID-19 pandemic in childhood, how can we fill the immunity gap? <italic toggle="yes">Infect. Dis. Now</italic>. <bold>51</bold>, 418&#8211;423. 10.1016/j.idnow.2021.05.004 (2021).<pub-id pub-id-type="pmid">33991720</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.idnow.2021.05.004</pub-id><pub-id pub-id-type="pmcid">PMC8114587</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>H</given-names></name><name name-style="western"><surname>Li</surname><given-names>S</given-names></name><name name-style="western"><surname>Yang</surname><given-names>H</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Z</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>Z</given-names></name></person-group><article-title>Resurgence of Mycoplasma pneumonia by macrolide-resistant epidemic clones in China</article-title><source>Lancet Microbe</source><year>2024</year><volume>5</volume><fpage>e515</fpage><pub-id pub-id-type="doi">10.1016/s2666-5247(23)00405-6</pub-id><pub-id pub-id-type="pmid">38244553</pub-id></element-citation><mixed-citation id="mc-CR34" publication-type="journal">Li, H., Li, S., Yang, H., Chen, Z. &amp; Zhou, Z. Resurgence of Mycoplasma pneumonia by macrolide-resistant epidemic clones in China. <italic toggle="yes">Lancet Microbe</italic>. <bold>5</bold>, e515. 10.1016/s2666-5247(23)00405-6 (2024).<pub-id pub-id-type="pmid">38244553</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S2666-5247(23)00405-6</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>XB</given-names></name><etal/></person-group><article-title>Current Mycoplasma pneumonia epidemic among children in shanghai: unusual pneumonia caused by usual pathogen</article-title><source>World J. Pediatr.</source><year>2024</year><volume>20</volume><fpage>5</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1007/s12519-023-00793-9</pub-id><pub-id pub-id-type="pmid">38231466</pub-id></element-citation><mixed-citation id="mc-CR35" publication-type="journal">Zhang, X. B. et al. Current Mycoplasma pneumonia epidemic among children in Shanghai: unusual pneumonia caused by usual pathogen. <italic toggle="yes">World J. Pediatr.</italic><bold>20</bold>, 5&#8211;10. 10.1007/s12519-023-00793-9 (2024).<pub-id pub-id-type="pmid">38231466</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s12519-023-00793-9</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR36"><label>36.</label><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhong</surname><given-names>P</given-names></name><etal/></person-group><article-title>Urban-Rural disparity in mortality patterns of respiratory diseases among older Adults - China, 1987&#8211;2021</article-title><source>China CDC Wkly.</source><year>2023</year><volume>5</volume><fpage>1125</fpage><lpage>1130</lpage><pub-id pub-id-type="doi">10.46234/ccdcw2023.210</pub-id><pub-id pub-id-type="pmid">38124883</pub-id><pub-id pub-id-type="pmcid">PMC10728557</pub-id></element-citation><mixed-citation id="mc-CR36" publication-type="journal">Zhong, P. et al. Urban-Rural disparity in mortality patterns of respiratory diseases among older Adults - China, 1987&#8211;2021. <italic toggle="yes">China CDC Wkly.</italic><bold>5</bold>, 1125&#8211;1130. 10.46234/ccdcw2023.210 (2023).<pub-id pub-id-type="pmid">38124883</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.46234/ccdcw2023.210</pub-id><pub-id pub-id-type="pmcid">PMC10728557</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR37"><label>37.</label><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shah</surname><given-names>SS</given-names></name><etal/></person-group><article-title>Blood cultures in the emergency department evaluation of childhood pneumonia</article-title><source>Pediatr. Infect. Dis. J.</source><year>2011</year><volume>30</volume><fpage>475</fpage><lpage>479</lpage><pub-id pub-id-type="doi">10.1097/INF.0b013e31820a5adb</pub-id><pub-id pub-id-type="pmid">21206393</pub-id><pub-id pub-id-type="pmcid">PMC3097278</pub-id></element-citation><mixed-citation id="mc-CR37" publication-type="journal">Shah, S. S. et al. Blood cultures in the emergency department evaluation of childhood pneumonia. <italic toggle="yes">Pediatr. Infect. Dis. J.</italic><bold>30</bold>, 475&#8211;479. 10.1097/INF.0b013e31820a5adb (2011).<pub-id pub-id-type="pmid">21206393</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/INF.0b013e31820a5adb</pub-id><pub-id pub-id-type="pmcid">PMC3097278</pub-id></mixed-citation></citation-alternatives></ref></ref-list></back></article>
        
    </metadata>
</record>
    </GetRecord>

</OAI-PMH>